The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Antimitotic Agents

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Antimitotic Agents.
Olatoyosi Odenike
Connection Strength
0.101
Antimitotic Agents
  1. Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Invest New Drugs. 2012 Jun; 30(3):1107-15.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.